1Phelps ME, Hung SC, Hoffman EJ, et al. Tomographic measurement of local cerebral glucose metabolic rate in humans with 18F-2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol, 1979, 6:371-388.
2Sokoloff L, Reivich M, Kennedy C, et al. The 14C-deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the the conscious and anesthetized albino rat. J Neurochem,1977, 28: 897-916.
3Reivich M, Kuhl D, Wolf A, et al. The 18Ffluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res, 1979, 44: 127-137.
4Huang SC, Phelps ME, Hoffman EJ, et al.Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol,1980, 238: E69-E82.
5Patlak CS, Blasberg RG, Fenstermacher JD.Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab, 1983, 3: 1-7.
6Kato A, Menon D, Diksic M, et al. Influence of the input function on the calculation of the local cerebral metabolic rate for glucose in the deoxyglucose method. J Cerob Blood Flow Metab,1984, 4: 41-46.
7Takikawa S, Dhawan V, Spetsieris P, et al.Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve.Radiology, 1993, 188: 131-136.
8Philips RL, Chen CY, Wong DF, et al. An improved method to calculate cerebral metabolic rates of glucese using PET. J Nucl Med, 1995,36: 1168-1179.
9Bonson KR, Grant SJ, Links JM, et al. Validation of an analytic method of calculating cerebral glucose metabolism .using PET. J Nucl Med, 2000, 41: 658-660.
2Lindholm P, Minn H, Leskinen-Kallio S, et al.Influence of the Blood Glucose Concentration on FDG Uptake in Cancer-a PET Study[J]. J Nucl Med, 1993, 34:1-6.
3Langen K J, Braun U, Rota Kops E, et al. The Influence of Plasma Glucose Levels on Fluorine-18-fluorodeoxyglucose Uptake in Bronchial Carcinomas[J]. J Nucl Med, 1993, 34:355-359.
4Wahl RL, Henry CA, Ethier SP. Serum Glucose:Effects on Tumor and Normal Tissue Accumulation of 2-[18 F] -fluoro-2-deoxy-D-glucose in Rodents With Mammary Carcinoma [J]. Radiology,1992, 183:643-647.
5Ishizu K, Nishizawa S, Yonekura Y, et al. Effects of Hyperglycemia on FDG Uptake in Human Brain and Glioma[J]. J Nucl Med, 1994, 35:1 104-1 109.
6Cremerius U, Bares R, Weis J, et al. Fasting Improves Discrimination of Grading 1 and Atypical or Malignant Meningioma in FDG-PET[J]. J Nucl Med, 1997, 38:26-30.
7Choi Y, Brunken RC, Hawkins RA, et al. Factors Affecting Myocardial 2-[F-18] fluoro-2-deoxy-D-glucose Uptake in Positron Emission Tomography Studies of Normal Humans[J]. Eur J Nucl Med, 1993, 20:308-318.
8C. S. Brock,S. R. Meikle,P. Price. Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?[J] 1997,European Journal of Nuclear Medicine(6):691～705
9J. J. Bax,M. A. Veening,F. C. Visser,A. Lingen,R. J. Heine,J. H. Cornel,C. A. Visser. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols[J] 1997,European Journal of Nuclear Medicine(1):35～41
